Barar, J., Kafil, V., Majd, M. H., Barzegari, A., Khani, S., Johari-Ahar, M. et al. (2015). Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells.Journal of Nanobiotechnology, 13, 26.

Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A. et al. (2020). Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet, 395(10224), 575–590. https://doi.org/10.1016/S0140-6736(20)30068-4.

Rahangdale, L., Mungo, C., O’Connor, S., Chibwesha, C. J., & Brewer, N. T. (2022). Human papillomavirus vaccination and cervical cancer risk. BMJ, 379, e070115 https://doi.org/10.1136/bmj-2022-070115.

Article  PubMed  Google Scholar 

Yoon, S., Choi, J. H., Kim, S. J., Lee, E. J., Shah, M., Choi, S. et al. (2019). EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression. Experimental & Molecular Medicine. 51(6), 1–12. https://doi.org/10.1038/s12276-019-0261-z.

Haimovici, A., Hofer, C., Badr, M. T., Bavafaye Haghighi, E., Amer, T., Boerries, M. et al. (2022). Spontaneous activity of the mitochondrial apoptosis pathway drives chromosomal defects, the appearance of micronuclei and cancer metastasis through the Caspase-Activated DNAse. Cell Death Disease, 13(4), 315. https://doi.org/10.1038/s41419-022-04768-y.

Wang, L., Qu, H., Ma, X. & Liu, X. (2022). Identification of oxidative stress-associated molecular subtypes and signature for predicting survival outcome of cervical squamous cell carcinoma. Oxidative Medicine and Cellular Longevity, 2022, 1056825 https://doi.org/10.1155/2022/1056825.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burd, E. M. (2003). Human papillomavirus and cervical cancer. Clinical Microbiology Reviews, 16(1), 1–17. https://doi.org/10.1128/CMR.16.1.1-17.2003.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng, D., Yan, K., Zhou, Y., Liang, H., Liang, J., Zhao, W. et al. (2016). Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis. Oncotarget, 7(40), 64575–64588. https://doi.org/10.18632/oncotarget.11810.

Tushaus, J., Muller, S. A., Shrouder, J., Arends, M., Simons, M., & Plesnila, N. et al. (2021). The pseudoprotease iRhom1 controls ectodomain shedding of membrane proteins in the nervous system. FASEB Journal, 35(11), e21962 https://doi.org/10.1096/fj.202100936R.

Article  PubMed  Google Scholar 

Peng, L., Tu, P., Wang, X., Shi, S., Zhou, X. & Wang, J. (2014). Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis. The Journal of Molecular Histology, 45(5), 555–563. https://doi.org/10.1007/s10735-014-9577-0.

Cui, Z., Tang, J., Chen, J. & Wang, Z. (2014). Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis. Cancer Cell International, 14, 47. https://doi.org/10.1186/1475-2867-14-47.

Liu, J., Xu, B., Xu, G., Zhang, X., Yang, X. & Wang, J. (2017). Reduced EphB6 protein in gastric carcinoma and associated lymph nodes suggests EphB6 as a gastric tumor and metastasis inhibitor. Cancer Biomark, 19(3), 241–248. https://doi.org/10.3233/CBM-160256.

Kang, M., Shi, J., Li, B., Luo, M., Xu, S. & Liu, X. (2019). LncRNA DGCR5 regulates the non-small cell lung cancer cell growth, migration, and invasion through regulating miR-211-5p/EPHB6 axis. Biofactors, 45(5), 788–794. https://doi.org/10.1002/biof.1539.

Toosi, B. M., El Zawily, A., Truitt, L., Shannon, M., Allonby, O. & Babu, M. (2018). EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours. Oncogene, 37(30), 4073–4093. https://doi.org/10.1038/s41388-018-0228-x.

Xiang, S., Wei, M., Zhao, L., Lin, A., & Xiong, Z. (2023). Integrated analyses of the expression and prognostic value of EPHB6 in cervical cancer and its correlation with immune infiltrates. Journal of Oncology, 2023, 2258906 https://doi.org/10.1155/2023/2258906.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marth, C., Landoni, F., Mahner, S., McCormack, M., Gonzalez-Martin, A., Colombo, N. et al. (2017). Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 28(suppl_4), iv72–iv83. https://doi.org/10.1093/annonc/mdx220.

Arbyn, M., Weiderpass, E., Bruni, L., de Sanjose, S., Saraiya, M. & Ferlay, J. et al. (2020). Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global Health, 8(2), e191–e203. https://doi.org/10.1016/S2214-109X(19)30482-6.

Article  PubMed  Google Scholar 

Huang, Y., Liu, R., Han, X., Hou, X., Tian, Y. & Zhang, W. (2022). Rab31 promotes the invasion and metastasis of cervical cancer cells by inhibiting MAPK6 degradation. The International Journal of Biological Sciences. 18(1), 112–123. https://doi.org/10.7150/ijbs.63388.

Kim, J., Chung, J. Y., Kim, T. J., Lee, J. W., Kim, B. G. & Bae, D. S. et al. (2018). Genomic network-based analysis reveals pancreatic adenocarcinoma up-regulating factor-related prognostic markers in cervical carcinoma. Frontiers in Oncology, 8, 465 https://doi.org/10.3389/fonc.2018.00465.

Article  PubMed  PubMed Central  Google Scholar 

Zhang H. M., Qi F. F., Wang J., Duan Y. Y., Zhao L. L., Wang Y. D. et al. (2022) The m6A methyltransferase METTL3-mediated N6-methyladenosine modification of DEK mRNA to promote gastric cancer cell growth and metastasis. International Journal of Molecular Sciences, 23(12). https://doi.org/10.3390/ijms23126451.

Takano, H., Nakamura, T., Tsuchikawa, T., Kushibiki, T., Hontani, K., Inoko, K. et al. (2015). Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice. Oncotarget, 6(38), 41063–41076. https://doi.org/10.18632/oncotarget.5729.

Pasquale, E. B. (2010). Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nature Reviews Cancer, 10(3), 165–180. https://doi.org/10.1038/nrc2806.

Liu, W., Ahmad, S. A., Jung, Y. D., Reinmuth, N., Fan, F., Bucana, C. D. et al. (2002). Coexpression of ephrin-Bs and their receptors in colon carcinoma. Cancer, 94(4), 934–939. https://doi.org/10.1002/cncr.10122.

Truitt, L., Freywald, T., DeCoteau, J., Sharfe, N. & Freywald, A. (2010). The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells. Cancer Research, 70(3), 1141–1153. https://doi.org/10.1158/0008-5472.CAN-09-1710.

Yu, J., Bulk, E., Ji, P., Hascher, A., Tang, M., Metzger, R. et al. (2010). The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer. Clin Cancer Res, 16(8), 2275–2283. https://doi.org/10.1158/1078-0432.CCR-09-2000.

Wang, Y., Zhang, Y., Mi, J., Jiang, C., Wang, Q., Li, X. et al. (2022). ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma. Oncogene, 41(29), 3680–3693. https://doi.org/10.1038/s41388-022-02380-0.

Li, R., Yan, Q., Tian, P., Wang, Y., Wang, J. & Tao, N. et al. (2019). CBX7 inhibits cell growth and motility and induces apoptosis in cervical cancer cells. Molecular Therapy - Oncolytics, 15, 108–116. https://doi.org/10.1016/j.omto.2019.09.002.

Article  CAS  PubMed  PubMed Central  Google Scholar